Ciox Health competitors

Thomas Mika previously served as the Chairman of the Board of Rennova Health, the successor company to CollabRx and its predecessor, Tegal Corporation, a semiconductor capital equipment company. On the Board of Directors of Tegal since its spin-out from Motorola in 1989, Mika assumed the roles of Chief Financial Officer in 2002, CEO in 2005 and Chairman & CEO in 2006, positions which he held until 2015. In 2015, Tegal merged with Rennova Health with Mika retaining the position of Chairman until joining POET in November 2016. Previously, Mika co-founded IMTEC, a boutique investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years, taking on the role of CEO in several ventures. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.

Crispin Teufel is a Board Member at Bellerophon Therapeutics; Chairman Of The Board at German American Chamber of Commerce of the Southern US, Inc.; and Chief Executive Officer at LINCARE HOLDINGS INC and is based in Washington, D.C.. He has worked as Head of IFRS Competence Center & External Reporting at Linde, Intern at Rosenfelt Christensen & West Engineering A/S, and Chief Financial Officer at LINCARE HOLDINGS INC. Crispin studied at University of Chicago Booth School of Business between 2018 and 2019; Saïd Business School, University of Oxford between 2009 and 2009; and Ministry of Finance State of Hessen between 2005 and 2005.

Tom Shields is a President at Shields Health Care Group. He has worked as Chairman/CEO/Founder at Shields Health Care Group. Thomas works or has worked as BOARD MEMBER at Trinity Catholic Academy and BOARD MEMBER at South Shore Chamber of Commerce. He studied at Stonehill College.

Greg Nulty is the Chief Financial Officer at Performance Health, a leader in consumer healthcare and the largest global manufacturer and distributor of products to the physical therapy, sports medicine, and rehabilitation markets. Greg has spent the past 16 years with Novartis Group, most recently serving as CFO of Sandoz’s nearly $4 billion North America business in Princeton, NJ since 2016. Prior to this, Greg was the head of Business Planning and Analysis for Sandoz globally from 2013 - 2016 in Munich, Germany, and between 2011 and 2013, he served as CFO of Sandoz’s Asia Pacific based in Singapore. Prior to this, Greg served as head of Business Planning and Analysis globally at Novartis’s Consumer Health division from 2009- 2011, after serving as CFO of Western Europe for Sandoz from 2005-2007. Greg began his career with Novartis as a senior controller. Prior to joining Novartis, he worked in corporate finance with Andersen and as an Auditor with Ernst & Young, both in his native South Africa, as well as with Merrill Lynch in London. Greg received his MBA from INSEAD and holds a Bachelor’s degree in Commerce from the University of Cape Town, where he graduated with high distinction.

Marty McKenna are a Chief Executive Officer at VERISMA SYSTEMS, INC.. They have worked as Various at GE Healthcare; President at Allscripts; and VP, Partnerships and Client Sales at Allscripts. Marty studied at Purdue University between 1990 and 1995 and University of Chicago Booth School of Business between 1998 and 2001.